miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton’s tyrosine kinase inhibition with Ibrutinib
2014 ◽
Vol 11
(4)
◽
pp. 265-271
◽
2019 ◽
pp. molcanres.0256.2018
◽